Dear Healthcare Professional

Title 20-Vgu-Metformin Additional Risk Minimization Measure Enbrel 20-Vgu-Metformin Additional Risk Minimization Measure Enbrel Additional Risk Minimization Measure Mabthera Alert- Substandard Paracetamol Suspension Amedin Recall Letter Association Of Ibandronic Acid And Anaphylaxis (Anaphylactic Reaction, Anaphylactic Shock) Azithromycin And Cardiovascular Risks Boxed Warning - Exjade (Deferasirox) DHCP Lettre Plaquenil - Ghana Final DHPL Ketoconazole For Publication0001 DHPL On Rare Events Of Thrombosis And Thrombocytopenia Following Vaccination With Covid-19 Vaccine Astrazeneca Diclofenac And Risk Of Cardiovascular Events (Heart Attack And Stroke) FDA DHCP Letter Valproate Gs FDA_Gh Valproate Guide For Healthcare Professionals Gadolinium Dhcp Letter0001 Losartan DHCP New Oral Ketoconazole And The Risk Of Severe Liver Injury, Adrenal Gland Problems And Harmful Drug Interactions Over-The-Counter Cold And Cough Preparations In Childrenfollow-Up To An Earlier Communication Paracetamol And The Risk Of Rare But Serious Skin Reactions Rare but serious allergic reactions Reporting Incidents Of Therapeutic Ineffectiveness As Adverse Events Reporting Medical Errors Restrictions On The Use Of Codeine As An Analgesic In Children And Adolescents Review Of The Safety Of Metamizole Sodium Safety Alert-Ibrance Safety Information On The Risk Of Development Of Anaphylactic Reactions To General Anaesthesia With Neuromuscular Blocking Agents (NMBAa) Safety Of (Dextro)Propoxyphene-Containing Products Suspected Oral Quinine Sulphate Induced Bleeding And Incomplete Abortion Update on safety of pioglitazone Vgu 0184 Safety Alert Recall Of Pfizers Accupril (Quinapril Hydrochloride) Vgu 0449 Substandard (Contaminated) Paediatric Medicines Identified In Who Region Of Africa Vgu-23-0125 Strengthened Risk Management For Sodium Valproate And Mandated Changes To The Product Information Vgu-23-0224 Fluoroquinolone Antibiotics Reminder Of Measures To Reduce The Risk Of Long-Lasting, Disabling And Potentially Irreversible Side Eff Vgu-23-0306 New Safety Measures On The Use Of Isotretinoin 17-700 Dhpl Acei - Dear Healthcare Professional 18-192-Potential For Increased Ltr With Clarithromycin 18-293-Suspension Of Mah For Cccs-Signed DHCPL wdt_ID wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at DATE TITLE 1 prmis 12/09/2024 10:54 PM Kelvin 15/01/2025 04:44 PM 03/01/2010 BOXED WARNING - EXJADE(DEFERASIROX) - DHCPL 2 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:00 PM 05/08/2012 ASSOCIATION OF IBANDRONIC ACID AND ANAPHYLAXIS (ANAPHYLACTIC REACTION, ANAPHYLACTIC SHOCK) - DHCPL 3 prmis 12/09/2024 10:54 PM prmis 12/09/2024 10:54 PM 08/02/2013 ORAL KETOCONAZOLE AND THE RISK OF SEVERE LIVER INJURY, ADRENAL GLAND PROBLEMS AND HARMFUL DRUG INTERACTIONS - DHCPL 4 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:05 PM 03/01/2017 RARE BUT SERIOUS ALLERGIC REACTIONS WITH THE SKIN ANTISEPTIC CHLORHEXIDINE GLUCONATE - DHCPL 5 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:07 PM 07/05/2017 UPDATE ON SAFETY OF PIOGLITAZONE - DHCPL 6 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:08 PM 11/02/2018 SUSPENSION OF MARKETING AUTHORIZATION FOR ORAL KETOCONAZOLE PRODUCTS - DHCPL 7 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 11:42 PM 12/03/2018 FOLLOW UP-SUSPENSION OF MARKET AUTHORIZATION OF CODEINE CONTAINING COUGH SYRUPS - DHCPL 8 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:16 PM 12/06/2018 RECALL OF AMLODIPIN-VALSATAN COMBINATION TABLETS - DHCPL 9 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 11:50 PM 23/01/2019 RESTRICTIONS TO PREVENT THE USE OF VALPROATE MEDICINES IN WOMEN AND GIRLS OF CHILDBEARING POTENTIAL - DHCPL 10 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 11:56 PM 27/02/2019 RESTRICTIONS ON THE USE OF FLUOROQUINOLONE DUE TO INCREASED RISK OF RUPTURES OR TEARS IN THE AORTA BLOOD VESSEL table.wpDataTable td.numdata { text-align: right !important; } /* pagination current page background color */ .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .paginate_button.current, .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .paginate_button.current:hover{ background-color:#FFFFFF !important; } /*pagination current page color */ .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .paginate_button.current, .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .paginate_button.current:hover{ color:#000000 !important; } /* pagination other pages hover color */ .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .paginate_button:hover:not(.disabled):not(.current), .wpDataTablesWrapper.wpDataTableID-31 .paginate_button.previous:hover:before, .wpDataTablesWrapper.wpDataTableID-31 .paginate_button.first:hover:before, .wpDataTablesWrapper.wpDataTableID-31 .paginate_button.next:hover:before, .wpDataTablesWrapper.wpDataTableID-31 .paginate_button.last:hover:before{ color:#929292 !important; } /* pagination background color */ .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate { background-color:#FFFFFF !important; } /* pagination color */ .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .paginate_button, .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .paginate_button.disabled:before, .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .paginate_button.disabled:hover:before, .wpDataTablesWrapper.wpDataTableID-31 .dataTables_paginate .ellipsis, .wpDataTablesWrapper.wpDataTableID-31 .paginate_button.previous:before, .wpDataTablesWrapper.wpDataTableID-31 .paginate_button.first:before, .wpDataTablesWrapper.wpDataTableID-31 .paginate_button.next:before, .wpDataTablesWrapper.wpDataTableID-31 .paginate_button.last:before{ color:#FFFFFF !important; }